Welcome to the Doctors' Portal
00:00 Sunday
Mediclinic News : US retracts plan to cut HIV/AIDS funds for SA


US retracts plan to cut HIV/AIDS funds for SA




News Description

BUSINESS DAY The US government said on Monday that it would provide $410m to SA’s HIV/AIDS programmes for the fiscal year starting October 1, highlighting how it still provides support to SA despite plans to slash funding. In 2012 it emerged that the US President’s Emergency Programme for Aids Relief (Pepfar) intended to cut its financial assistance to SA by 50% or more over five years. Strong lobbying by the Department of Health ensured it never cut back on the scale initially envisaged, according to deputy director-general for HIV/AIDS, tuberculosis and maternal, child and women’s health, Yogan Pillay. "There’s been a realisation by the US government that if SA doesn’t get on top of its HIV epidemic, the whole region and (the world) won’t be able to either. "Given the new targets that have been adopted — 90-90-90 and ending the epidemic by 2030 — there has been a renewed commitment to funding SA," he said. The 90-90-90 targets, set by the UN’s HIV/AIDS programme, UNAIDS, aim to ensure that 90% of people living with HIV/AIDS know their status, that 90% of them get treatment, and that the virus is suppressed in 90% of patients on treatment. Health Minister Aaron Motsoaledi told Business Day in an interview last week the US government recognised that if it pulled back too hard, it risked reversing the gains the country had made. "My belief is they realise if the programme in SA is not successful there will be no global success and all the money they have spent in the past will have been in vain." He said 80% of SA’s HIV/AIDS programmes were funded from the fiscus, and Pepfar was the biggest foreign donor. Figures provided by the US embassy show that while Pepfar’s core Country Operational Plan (COP) funding to SA fell from a peak of $590m in 2008 to $413m in 2015, the cut originally planned from 2012 never materialised. The COP funding for 2012 was $524m, in 2013 it dipped to $484m, and in 2014 it was $459m. "Based on the high burdens of HIV and TB in SA, strong leadership and financial commitment by the South African government, and the highly effective partnership between the US and SA in the HIV/AIDS response, Pepfar funding in SA for 2016 will exceed the amount projected in the 2012 plan," said embassy spokeswoman Cynthia Harvey. In addition to Pepfar’s 2016 COP funding of $410m, it will provide $24m for voluntary medical male circumcision and $33m for the DREAMS initiative, which aims to reduce new HIV infections in teenage girls and young women. Back to top EHEALTH DRIVES IMPROVED HEALTHCARE DELIVERY MODELS IN AFRICA 13 July 2016 eHealth News Sikhumbuzo Hlabangane A new analysis from Frost & Sullivan has predicted that healthcare IT and the pharmaceutical industry in Africa will experience substantial growth in 2016. A new analysis from Frost & Sullivan has predicted that healthcare information technology (IT) and the pharmaceutical industry in Africa will experience substantial growth in 2016. The new analysis, titled 2016 Africa Healthcare Industry Outlook, found that the global shift towards value-based healthcare is improving the provision of health in Africa. And increased investment in both the pharmaceutical and healthcare IT sectors will see local business flourish in South Africa, Kenya, Ethiopia and other emerging economies. The study identified a host of factors anticipated to have a positive effect on the African healthcare industry, which includes the rising middle class, introduction of local manufacturers, and support from national governments. Handheld medical devices, mHealth, micro health insurance, and in-country manufacture of drugs will also gain momentum, resulting in vast improvements to client care delivery models. Frost & Sullivan says the study will assist stakeholders within industry to design solutions and strategies that efficiently meet the demands of the market. “Despite the poor economic status of African countries, there is a collective drive to reduce and eliminate the incidence of life threatening diseases in Africa,” said Industry Analyst for Global Transformational Health at Frost & Sullivan, Aditi Bhalla. “Key enablers for this drive will include eHealth technologies, like mHealth and point-of-care testing (POCT). mHealth and video telemedicine solutions are already being used to streamline patients’ data, while innovative, easy-to-use POCT and home diagnostic solutions assist with accelerating access to care,” continued Bhalla. Furthermore, low-cost pharmaceutical drugs and equipment will be specifically designed for Africa and will substitute traditional, costly options. In-country production of drugs will increase, with prominent industry manufacturers and brands entering the market, leveraging joint ventures with governing bodies, and assisting in skills training of community healthcare workers for improved healthcare solutions. “With Mega Trends analyses indicating that Africa is the only continent with the potential to achieve double-digit economic growth within the next decade, healthcare vendors, providers and regulatory bodies will do well to synchronise their services for transforming health in Africa,” said Bhalla. “The preference for private healthcare solutions, primarily due to the increasing per capita income in sub-Saharan Africa, makes it essential for private vendors and providers to keep abreast of the changes in the industry,” noted Bhalla. To address these needs, Frost & Sullivan’s Global Transformational Health team has created a common platform for healthcare industry stakeholders to access relevant information and strategize for a profitable future.
Created at 2016/07/21 09:46 AM by Mediclinic
Last modified at 2016/07/21 09:46 AM by Mediclinic